Location of Repository

Adaptive processes in skeletal muscle: molecular regulators and genetic influences

By Claire E. Stewart and Jörn Rittweger

Abstract

Full-text of this article is available at http://www.ismni.org/jmni/pdf/23/09STEWART.pdf

Topics: Training, Exercise, Physiology, Exercise Genes, Hypertrophy, Atrophy
Publisher: The International Society of Musculoskeletal and Neuronal Interactions
Year: 2010
OAI identifier: oai:www.e-space.mmu.ac.uk:2173/97846

Suggested articles

Preview

Citations

  1. (1968). Retention of differentiation potentialities during prolonged cultivation of myogenic cells. doi
  2. (1988). Myogenic lineage determination and differentiation: evidence for a regulatory gene pathway. Cell doi
  3. (1987). Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell doi
  4. (2002). Myogenic regulatory factors and the specification of muscle progenitors in vertebrate embryos. Annu Rev Cell Dev Biol
  5. (2001). Regulation and functions of myogenic regulatory factors in lower vertebrates. doi
  6. (2005). The growth factor myostatin, a key regulator in skeletal muscle growth and homeostasis. doi
  7. (2002). Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. doi
  8. (2004). Skeletal muscle — from molecules to movement. 1st Ed. Churchill
  9. (1969). Muscle fibre growth in five different muscles in both sexes of mice.
  10. (1983). Protein turnover measured in vivo and in vitro in muscles undergoing compensatory growth and subsequent denervation atrophy. Biochem J
  11. (2001). What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Curr Opin Clin Nutr Metab Care doi
  12. (2002). Induction of cachexia in mice by systemically administered myostatin. Science
  13. (2000). Myostatin and insulin-like growth factor-I and -II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight. doi
  14. (1997). Genetic influences on muscle strength, lean body mass, and bone mineral density: a twin study. J Bone Miner Res doi
  15. (1991). Genetic influences and grip strength norms in the NHLBI twin study males aged 59-69. Ann Hum Biol doi
  16. (2000). Stability and change in genetic and environmental influences on hand-grip strength in older male twins.
  17. (2002). Hand grip strength: a phenotype suitable for identifying genetic variants affecting mid- and late-life physical functioning. Genet Epidemiol doi
  18. (1998). Strength training: importance of genetic factors. Med Sci Sports Exerc doi
  19. (1998). Determinants of paraspinal muscle cross-sectional area in male monozygotic twins. Phys Ther
  20. (2004). The role of genetics and environment in lifting force and isometric trunk extensor endurance. Phys Ther
  21. (2004). The genetic contribution to muscle strength, knee pain, cartilage volume, bone size, and radiographic osteoarthritis: a sib pair study. Arthritis Rheum doi
  22. (2004). Determinants and upper-limit heritabilities of skeletal muscle mass and strength. doi
  23. (2004). Heritability of maximal isometric muscle strength in older female twins. doi
  24. (2002). Muscle-specific inactivation of the IGFI receptor induces compensatory hyperplasia in skeletal muscle. doi
  25. (2001). Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet
  26. (1991). Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. Mol Endocrinol doi
  27. (2003). Role of calcineurin in striated muscle: development, adaptation, and disease. doi
  28. (2003). Calcineurin initiates skeletal muscle differentiation by activating MEF2 and MyoD. Differentiation doi
  29. (2001). A calcineurin- and NFATdependent pathway regulates Myf5 gene expression in skeletal muscle reserve cells.
  30. (2000). Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo.
  31. (2003). Skeletal muscle reprogramming by activation of calcineurin improves insulin action on metabolic pathways. doi
  32. (2003). Temporal alterations in protein signaling cascades during recovery from muscle atrophy. doi
  33. (1996). Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. doi
  34. (1997). Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differenC.E.H. Stewart
  35. (2000). Generation of tension by skinned fibers and intact skeletal muscles from desmin-deficient mice. Biochem Biophys Res Commun doi
  36. (2002). Models of skeletal muscle to explain the increase in passive stiffness in desmin knock-out muscle. doi
  37. (2003). Lower active force generation and improved fatigue resistance in skeletal muscle from desmin-deficient mice.
  38. (2003). Attenuating muscle wasting: Cell and gene therapy approaches. Curr Genom doi
  39. (1993). Selective accumulation of MyoD and myogenin mRNAs in fast and slow adult skeletal muscle is controlled by innervation and hormones. Development
  40. (1993). Through thick and thin: wasting, obesity, and TNF alpha. Cell doi
  41. (1992). The role of cytokines in cancer cachexia. doi
  42. (1994). Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med doi
  43. (1998). Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knock-out mice. Mol Cell Endocrinol doi
  44. (2003). Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. doi
  45. (2004). The molecular basis of skeletal muscle atrophy.
  46. (2004). Myostatin: a therapeutic target for skeletal muscle wasting. Curr Opin Clin Nutr Metab Care doi
  47. (1997). A deletion in the bovine myostatin gene causes the doublemuscled phenotype in cattle. Nat Genet doi
  48. (2002). Functional improvement of dystrophic muscle by myostatin blockade. Nature doi
  49. (1997). Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature doi
  50. (2003). Molecular mechanisms modulating muscle mass. Trends Mol Med doi
  51. (2001). Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells.
  52. (2003). Myostatin gene expression is reduced in humans with heavy-resistance strength training: a brief communication. Exp Biol Med (Maywood)
  53. (2002). The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev
  54. (1994). Vitamin D receptor genotypes in osteoporosis. Lancet doi
  55. (1997). Quadriceps and grip strength are related to vitamin D receptor genotype in elderly non-obese women. J Bone Miner Res doi
  56. (2004). Genetic variation in the human vitamin D receptor is associated with muscle strength, fat mass and body weight in Swedish women. doi
  57. (2004). Bradykinin receptor gene variant and human physical performance.
  58. (2002). Association of a null mutation in the CNTF gene with early onset of multiple sclerosis. Arch Neurol doi
  59. (2003). C174T polymorphism in the CNTF receptor gene is associated with fat-free mass in men and women.
  60. (2001). CNTF genotype is associated with muscular strength and quality in humans across the adult age span.
  61. (2003). Carbohydrate ingestion influences skeletal muscle cytokine mRNA and plasma cytokine levels after a 3-h run. doi
  62. (2004). Association of interleukin-15 protein and interleukin15 receptor genetic variation with resistance exercise training responses.
  63. (2002). Polymorphism of the IGF2 gene, birth weight and grip strength in adult men. Age Ageing doi
  64. (2001). Polymorphic variation in the human myostatin (GDF-8) gene and association with strength measures in the Women's Health and Aging Study II cohort. doi
  65. (1999). Frequent sequence variation in the human myostatin (GDF8) gene as a marker for analysis of muscle-related phenotypes. Genomics doi
  66. Vitamin D receptor genotypes in osteoporosis. In: Glorieux FH, Pike JW, Feldman D (eds) Vitamin D.
  67. (2002). Serum myostatin-immunoreactive protein is increased in 60-92-year-old women and men with muscle wasting.
  68. (2001). Effects of resistance train-C.E.H. Stewart
  69. (2001). Identification of ubiquitin ligases required for skeletal muscle atrophy. Science
  70. (2001). Atrigin-1, a muscle specific gene F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA
  71. (2001). Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. Endocrinology doi
  72. (2003). The role of titin in muscular disorders. Ann Med doi
  73. (2004). A gene for speed? The evolution and function of alpha-actinin-3. Bioessays doi
  74. (2004). Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle. Exp Cell Res doi
  75. (2004). The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ Res doi
  76. (2001). NO message from muscle. Microsc Res Tech doi
  77. (2004). Limb-girdle muscular dystrophies – from genetics to molecular pathology. doi
  78. (2000). Animal models for muscular dystrophy: valuable tools for the development of therapies. Hum Mol Genet doi
  79. (2004). Congenital myopathies: diseases of the actin cytoskeleton. doi
  80. (2000). Form follows function: how muscle shape is regulated by work.
  81. (1996). Myosin heavy chain turnover in cultured neonatal rat heart cells: effects of [Ca2+]i and contractile activity.
  82. (1996). Samarel AM. Mechanical regulation of cardiac myocyte protein turnover and myofibrillar structure.
  83. (1992). Genetics of aerobic and anaerobic performances. Exerc Sport Sci Rev doi
  84. (2000). Soft tissue body composition differences in monozygotic twins discordant for spinal cord injury. doi
  85. (1998). Vlietinck RF. Inheritance of static and dynamic arm strength and some of its determinants. Acta Physiol Scand doi
  86. (2002). Identical twins are discordant for markers of eccentric exercise-induced muscle damage. doi
  87. (2002). Heritability of explosive power and anaerobic capacity in humans. doi
  88. (1977). Physical capacity in twins. Acta Genet Med Gemellol (Roma)
  89. (1984). Genetic influences of muscle mass metabolism and function in smokers and non-smokers. A study on smoking-discordant monozygous twins. Acta Physiol Scand doi
  90. (2003). The effect of training in male prepubertal and pubertal monozygotic twins. doi
  91. (2002). Fascicle length of gastrocnemius muscles in monozygous twins. doi
  92. (2003). Effect of aging on human muscle architecture.
  93. (2002). Influence of long-term bed rest on muscle architecture and tendon mechanical properties.
  94. (2002). Genetic factors in physical activity levels: a twin study. doi
  95. (1982). A short questionnaire for the measurement of habitual physical activity in epidemiological studies.
  96. (2003). Insulin-like growth factor action and skeletal muscle growth, an in vivo perspective. doi
  97. (1993). Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell doi
  98. (1993). IGFI is required for normal embryonic growth in mice. Genes Dev doi
  99. (1995). Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. doi
  100. (1998). Viral mediated expression of insulinlike growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA doi
  101. (1994). Signaling by insulin-like growth factors in paralyzed skeletal muscle: rapid induction of IGF1 expression in muscle fibers and prevention of interstitial cell proliferation by IGF-BP5 and IGF-BP4.
  102. (1989). Induction of insulin-like growth factor I messenger ribonucleic acid during regeneration of rat skeletal muscle. Endocrinology doi
  103. (1987). Regenerating skeletal muscle cells express insulin-like growth factor I. Acta Physiol Scand doi
  104. (1990). Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth.
  105. (2001). Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol
  106. (2002). Different modes of hypertrophy in skeletal muscle fibers. doi
  107. (1997). Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differen-C.E.H. Stewart
  108. (2002). Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1. doi
  109. (1999). Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet doi
  110. (2000). The ACE gene and muscle performance. Nature
  111. (2004). The ACE gene and endurance performance during the South African Ironman Triathlons. Med Sci Sports Exerc doi
  112. (2000). Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload. Exp Physiol doi
  113. (2004). Exploration of myostatin polymorphisms and the angiotensin-converting enzyme insertion/deletion genotype in responses of human muscle to strength training. doi
  114. (2003). ACE genotype and physical training effects: a randomized study among elderly Danes. Aging Clin Exp Res doi
  115. (2001). Genetic influences of muscle mass
  116. (2003). ACTN3 genotype is associated with human elite athletic performance. doi
  117. (2005). ACTN3 genotype is associated with increases in muscle strength and response to resistance training in women. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.